Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824Phase 3Completed
- Sponsor
- Tufts University
- Start
- Mar 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of conjugated estrogens in coronary heart disease (CHD) (3 arms), sponsored by Tufts University. Primary endpoint: High-Density Lipoprotein subpopulation distribution and composition at 1 year. Started Mar 2004; status: completed.
02
Drugs
conjugated estrogens
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00083824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083824.